Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Return on Sales: 2022-2025

Historic Return on Sales for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to 1.65%.

  • InMed Pharmaceuticals' Return on Sales fell 34.00% to 1.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.71%, marking a year-over-year decrease of 34.00%. This contributed to the annual value of 1.65% for FY2025, which is 2.00% up from last year.
  • According to the latest figures from FY2025, InMed Pharmaceuticals' Return on Sales is 1.65%, which was up 1.08% from 1.67% recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Return on Sales peaked at 1.65% during FY2025, and registered a low of 17.07% during FY2022.
  • For the 3-year period, InMed Pharmaceuticals' Return on Sales averaged around 1.75%, with its median value being 1.67% (2024).
  • In the last 5 years, InMed Pharmaceuticals' Return on Sales soared by 1,515bps in 2023 and then dropped by 2bps in 2025.
  • Over the past 4 years, InMed Pharmaceuticals' Return on Sales (MRY) stood at 17.07% in 2022, then soared by 89bps to 1.92% in 2023, then grew by 13bps to 1.67% in 2024, then grew by 1bps to 1.65% in 2025.
  • Its last three reported values are 1.65% in FY2025, 1.67% for FY2024, and 1.92% during FY2023.